Venomics AI
India · Biotech · AI
Venom biology, AI and laboratory screening for therapeutic discovery.
Product
Venomics AI develops a discovery platform to turn venom-derived molecules into therapeutic leads. The Bengaluru company brings together biological sequencing, computational analysis and laboratory experiments to identify and improve promising candidates.
Its Venom Atlas connects molecular information with evidence about biological function. AI helps prioritise candidates, while screening tests their activity and selectivity. Results feed back into the company’s models and subsequent molecule design.
Founded by Kartik Sunagar and Vinay Prabhu, the company combines toxinology research with machine learning and computational biology. Its research interests include pain, antimicrobial resistance and other areas where selective venom-derived molecules may support drug development.
Funding history
1 round · 1 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| Pre-seed | $2.7M | South Park Commons — LeadSpeciale Invest — LeadOperators Studio — Participant |